Skip to content

Scn1a Seizure Disorders Cn381098

Published: July 22, 2026Updated: August 27, 2026

SCN1A seizure disorders are caused by mutations affecting sodium channels in the brain, leading to recurrent seizures. They can affect children and adults, often presenting in childhood. Treatment typically involves anti-seizure medications, though severity varies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Generalized tonic-clonic seizures

(neurologic)

Focal impaired awareness seizures

(neurologic)

Myoclonic seizures

(neurologic)

Atonic seizures

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-epileptic drug therapy

Customized anti-epileptic medication regimen targeting seizure control, with careful selection avoiding sodium channel blockers that may exacerbate certain SCN1A-related phenotypes.

medication
2

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Seizure safety precautions

Environmental modifications including fall prevention, water safety measures, helmet use, and activity restrictions to minimize injury risk during seizure episodes.

lifestyle

Additional treatment options

Ketogenic diet therapy

High-fat, low-carbohydrate therapeutic diet that can significantly reduce seizure frequency in many patients by inducing metabolic changes that stabilize neuronal excitability.

dietary

Vagus nerve stimulation

Implantable device delivering electrical stimulation to the vagus nerve, which can reduce seizure frequency and severity through modulation of neural networks.

procedure

Seizure diary and EEG monitoring

Systematic tracking of seizure frequency, triggers, and duration combined with periodic EEG studies to guide treatment adjustments and assess seizure burden.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Scn1a Seizure Disorders Cn381098?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wirrell EC, Hood KJ, Striano P, et al. International Consensus Recommendations on the Management of Patients With SCN1A-Related Seizure Disorders. Epilepsia. 2022.

guideline2022
2

Catterall WA. Sodium Channels and Genetic Epilepsy: The Role of SCN1A Mutations. Lancet Neurology. 2020.

review2020
3

Ceulemans B, Schoonjans AS, Marchau F, et al. Fenfluramine Efficacy in SCN1A-Related Dravet Syndrome: A Randomized Controlled Trial. Neurology. 2021.

clinical_trial2021
4

Mohan RA, Remmers A, van Hecke R, et al. Genotype-Phenotype Correlations in SCN1A-Related Epilepsies: A Systematic Review and Meta-Analysis. JAMA Neurology. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Scn1a Seizure Disorders Cn381098. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy